EMBL is Europe's laboratory for the life sciences. The Patil group uses a combination of modelling, bioinformatics, and experimental approaches to study metabolic networks and how they are controlled.
EMBL is an international organisation employing around 2000 people in 5 European locations, with headquarters in Heidelberg, Germany. Its mandates include the advancement of European basic science particularly in Molecular Biology, the development of advanced technology and instruments, the provision of training and services to Member States, as well as technology transfer.
Dr Kiran Patil is a group leader in the Structural and Computational Biology Unit (one out of eight at EMBL, ca. 150 people) located in Heidelberg. The group is home to ~15 talented young scientists covering both computational and experimental tools needed to design and build cell factories.
EMBL's key contributions to the ShikiFactory100 project include: analysis of the side effects of new compounds, and the development of genome-scale metabolic models. EMBL are leaders of Work Package 5: In silico Metabolic Engineering, and key contributors to Work Package 3: Design and Chemical Synthesis of New Products, Work Package 6: Rapid Prototyping and Screening, and Work Package 7: Cell Factory Construction.
The Principal Investigator for EMBL in the ShikiFactory100 project is Dr Kiran Patil.
Find out more about EMBL here.
Manchester, United Kingdom
La Coruña, Spain
York, United Kingdom